-transparent.png){kind=logo}
Recent studies evaluating the effect of slow releasing enteric-coated aspirin formulations have reported contradictory findings regarding the bioavailability of the active molecule in the circulating blood and the length of duration of the inhibitory effect on platelet function. In the present study, we have evaluated the effect of a single dose of two commercially available enteric-coated aspirins on platelet arachidonic acid metabolism and function. A single dose of slow releasing aspirin was as effective as fast acting regular aspirin in its effect on cyclooxygenase activity and platelet function in both human and canine platelets. However, in view of its slow releasing property, the onset of inhibition was considerably delayed compared to the action of fast acting aspirin in those subjects who ingested enteric-coated aspirins.
G H Rao, and
E Radh, and
G J Johnson, and
J G White
January 1980,
Stroke,
G H Rao, and
E Radh, and
G J Johnson, and
J G White
January 1983,
Thrombosis research,
G H Rao, and
E Radh, and
G J Johnson, and
J G White
January 1992,
Indian heart journal,
G H Rao, and
E Radh, and
G J Johnson, and
J G White
September 2002,
Alimentary pharmacology & therapeutics,
G H Rao, and
E Radh, and
G J Johnson, and
J G White
April 2007,
The American journal of medicine,
G H Rao, and
E Radh, and
G J Johnson, and
J G White
February 1983,
Southern medical journal,
G H Rao, and
E Radh, and
G J Johnson, and
J G White
December 1986,
The Journal of laboratory and clinical medicine,
G H Rao, and
E Radh, and
G J Johnson, and
J G White
May 1991,
American heart journal,
G H Rao, and
E Radh, and
G J Johnson, and
J G White
October 1985,
The Journal of rheumatology,
G H Rao, and
E Radh, and
G J Johnson, and
J G White
January 1982,
European journal of clinical pharmacology,
